5 Easy Facts About Stenabol SR9009 for Sale Described
To be a partial agonist, YK11 only partly activates androgen receptors and can compete straight with endogenous Testosterone and DHT for receptor activation.
It absolutely was initially developed for a cure for osteoporosis and afterwards located successful from breast cancer.
The bottom line